Sjögren syndrome was chosen as a clinical model to study acinar salivary deficiencies in the development of laryngopharyngeal reflux (LPR). The objective of this prospective cohort study was to compare salivary epidermal growth factor (EGF) concentrations of patients with Sjögren syndrome with and without LPR and gastroesophageal reflux disease (GERD) with normal controls. LPR was diagnosed with positive scores on the Reflux Symptom Index and Reflux and Reflux Finding Score, corroborated by esophagogastroduodenoscopy and/or 24-hour pH-metry. Salivary EGF concentrations of both unstimulated and mechanically stimulated saliva were established using enzyme-linked immunosorbent assay, and the significance level was set at 95%. Twenty-one patients and 19 controls were studied. All patients had LPR and 60% also had GERD. The mean salivary EGF concentration of unstimulated and stimulated saliva in the control group was 1,751.37 pg/ml and 544.76 pg/ml, respectively. Unstimulated and stimulated salivary EGF concentrations in the study group were 2,534.65 pg/ml and 920.69 pg/ml, respectively. These differences were not statistically significant. Body mass index, presence of erosive esophagitis, or severity of hyposalivation did not significantly influence salivary EGF concentrations. LPR and GERD are highly prevalent in patients with Sjögren syndrome. Unlike previous studies in which significant EGF deficiencies were found in patients with reflux laryngitis and GERD, patients with Sjögren syndrome seem to have reflux caused by a decrease in clearance capacity and not in specific salivary components.
Introduction
Saliva plays a key role in the homeostasis of the digestive tract, both by its inorganic components, such as fluid chloride and bicarbonate, and also by its organic components (i.e., biologically active proteins, such as the epidermal growth factor [EGF], transforming growth factor [TGF], and many others). [1] [2] [3] [4] [5] Dyspeptic disease and gastroesophageal reflux disease (GERD) have been associated with reduced salivary flow of both intrinsic (Sjögren syndrome) and extrinsic origin (postradiation therapy or drug-induced). [6] [7] [8] The incidence of the supraesophageal manifestations of GERD, such as laryngopharyngeal reflux (LPR), also seems to be greater in patients with reduced salivary flow. 9, 10 Whether the total lack of salivary volume or a specific deficiency of the salivary components contributes to these findings is unclear.
Significant reductions in salivary EGF concentrations have been reported in animals and humans with dyspeptic disease. 3, 5, 11, 12 Likewise, salivary EGF deficiencies have been found in adults with LPR. 13, 14 EGF seems to be the most active of the salivary proteins that contributes to the rapid regeneration of the digestive tract lining by inducing DNA proliferation and neoangiogenesis. [15] [16] [17] The proteic content of saliva, as well as EGF, is produced by the acinar cells of the salivary glands, especially the parotid and submandibular glands. 1, 17, 18 Sjögren syndrome is an autoimmune disorder of the exocrine glands that is commonly associated with reduced salivary flow. 7, 19 Because Sjögren syndrome affects primarily the acinar cell, it was selected as a clinical model to study the influence of acinar salivary flow deficiencies in the generation of GERD and LPR.
The objective of the current study was to compare salivary EGF concentrations of patients with Sjögren syndrome with and without LPR with that of normal controls in an attempt to establish whether the previously reported salivary EGF deficiencies could account for the development of LPR in this population.
Patients and methods
Following Institutional Review Board approval (protocol #034/07), 21 adults diagnosed with Sjögren syndrome based on the American-European criteria were included in the current study. 19 The patient population was selected from the otolaryngology outpatient clinic of a tertiary teaching hospital. All patients that met the inclusion and exclusion criteria were consecutively enrolled in the study, after proper consent.
The diagnosis of LPR relies largely on clinical suspicion and involves the presence of suggestive symptoms and videolaryngoscopic signs of laryngopharyngeal inflammation. [20] [21] [22] To avoid bias, rigid exclusion criteria for other possible causes of chronic pharyngitis and laryngitis were adopted for the current study. Thus, patients with acute or chronic allergic rhinitis or sinusitis, pulmonary disease, and those with a history of surgery to the head and neck or digestive tract were excluded from the study.
Patients treated with drugs known to alter salivary flow and gastric secretions (i.e., diuretics, antihistamines, inhaled steroids, asthma inhalers, neuroleptics, psychotropics, proton pump inhibitors, prokinetics, and H 2 receptor antagonists) who were unable to discontinue the drug at least 20 days before entering the protocol were also excluded. Finally, patients reporting chronic lung disease, a history of laryngeal cancer, previous radiation therapy, or use of tobacco and alcohol were excluded. 23 Serving as controls were 19 healthy volunteers without clinical signs of Sjögren syndrome or LPR, with the same exclusion criteria as mentioned above.
All participants underwent a complete head and neck examination and videolaryngoscopy. Body mass index (BMI), expressed in kg/m 2 , was calculated for further comparison of the groups.
The diagnosis of LPR was based on two clinically validated tools, the Reflux Symptom Index (RSI) 24 and the Reflux Finding Score (RFS). 25 An RSI >13 and an RFS >7 were considered positive for LPR. 24, 25 Laryngos-copies were recorded and RFS scores were established blindly by two experienced laryngologists. If scores disagreed by >2 points, a consensus was reached by the two examiners. Only patients who consistently presented with RFS scores >7 were considered positive for LPR.
Further diagnostic investigation was completed with esophagogastroduodenoscopy (EGD). Patients who did not present with endoscopic confirmation of GERD were further investigated with esophageal manometry and a 24-hour double-probe pH-metry. Endoscopic signs of GERD were considered to be erosive esophagitis and Barrett esophagus. 26 Pathologic proximal reflux on double-probe esophageal pH-metry was considered as any single decline of pH of <4 preceded by a distal drop, regardless of its duration, excluding the postprandial period. 27, 28 Pathologic distal reflux was established based on the DeMeester score. 29 To summarize, the final diagnosis of LPR was thus based on a positive RSI and RFS corroborated by either a positive EGD or a positive pH-metry.
Controls were healthy volunteers recruited from the staff and the patients' families who had no history of digestive or laryngopharyngeal disease, who fit the exclusion criteria, and who had an RSI <13 and an RFS <7. Controls did not undergo additional testing.
Following a previously established protocol, two whole saliva samples were obtained from participants: one unstimulated and the other after mechanical stimulation by chewing a 25-cm 2 strip of Parafilm M (Pechiney Plastic Packaging; Chicago). 13, 14, 29, 30 Saliva samples were spun, and the supernatant was separated and stored at -20˚C until final analysis. EGF concentrations were established using a commercially available ELISA kit (Quantikine, R&D Systems Inc., Minneapolis) and expressed in pg/ml.
Patients with Sjögren syndrome were further subdivided into 2 groups according to the severity of hyposalivation for the purpose of comparing salivary EGF concentration. Mild hyposalivation was defined as a whole unstimulated salivary volume between 1 and 3 ml and/or whole stimulated salivary volume between 7 and 15 ml. Hyposalivation was considered to be severe when whole unstimulated salivary volume was <1 ml and/or whole stimulated salivary volume <7 ml. 7, 9, 18 Patients with Sjögren syndrome were also subdivided into 2 groups according to the presence of erosive esophagitis, and salivary EGF concentration was compared between these groups.
Results were tabled and statistical analysis was carried out using commercial software. Parametric data were analyzed with the Student t test and ANOVA. Comparisons of salivary EGF concentrations between samples were made using the Mann-Whitney test and the Wilcoxon test. The significance level was established at 5% (p < 0.05).
Results
All 21 patients were women aged 44 to 74 years (mean: 57.8 ± 8.8). Eleven patients presented with primary Sjögren syndrome and 10 had secondary Sjögren syndrome (5 with rheumatoid arthritis [RA], 4 with systemic lupus erythematosus [SLE], and one with both SLE and RA). Patients had been diagnosed with Sjögren syndrome on average 5 ± 2.5 years before entering the study protocol. The control group consisted of 19 healthy adult women aged 41 to 75 years (mean: 53.6 ± 11.3). Mean BMI was 26.4 ± 3.7 and 26.7 ± 3.6 kg/m 2 in the study and control groups, respectively. No statistically significant difference was found in age and BMI (p = 0.826) between study and control groups.
The mean RSI for the study group was 20 ± 6.9 points and the mean RFS was 12.6 ± 2.6 points. The mean RSI for the control group was 2.6 ± 3.5 points and the mean RFS was 2.9 ± 1.6 points. A statistically significant difference was found in the mean RSI and mean RFS between patients with Sjögren syndrome and healthy controls (p < 0.001).
Eight patients were found to have erosive esophagitis, 2 patients presented with nonerosive esophagitis, and 11 presented without esophagitis. No patient in this series had Barrett esophagus. All 13 patients without erosive esophagitis presented with pathologic reflux at the proximal probe, 5 of whom also presented with pathologic reflux at the distal probe (table 1). Four of the 13 patients who underwent esophageal manometry had esophageal dysmotility, another 4 presented with hypotonic lower esophageal sphincter (LES), and one presented with hypertonic LES. The remaining 4 patients had no manometric abnormalities (table 1) . The mean volume of unstimulated and stimulated saliva in the study group was 1.4 ± 1.4 ml and 5.0 ± 5.1 ml, respectively. The mean volume of unstimulated and stimulated saliva in the control group was 3.4 ± 2.0 ml and 11.0 ± 6.7 ml, respectively. Both unstimulated and stimulated salivary volumes were significantly larger in controls when compared to patients with Sjögren syndrome (p < 0.003), as expected.
There was no statistically significant difference in the salivary EGF concentrations when comparing patients with primary and secondary Sjögren syndrome; therefore, they were studied as a single group.
No statistically significant difference was found between patients and controls with respect to EGF concentrations of both unstimulated (2,534.7 ± 2,727.3 vs. 1,751.4 ± 1,179.4 pg/ml; p = 0.310) and stimulated saliva (920.0 ± 822.1 vs. 544.8 ± 505.0 pg/ml; p = 0.091) (table 2). Mechanical stimulation caused a statistically significant decrease in salivary EGF concentrations in both the study group (mean decline of 56%; p = 0.002) and in controls (mean decline of 63%; p < 0.001) (table 2) .
No statistically significant difference was found in the EGF concentrations of whole unstimulated saliva between patients with mild (1,826.14 ± 692.4 pg/ml) and those with severe hyposalivation (3, 178 .76 ± 3,672.38 pg/ml; p = 0.863) (table 3) . Mastication led to a nonsignificant decrease in salivary EGF concentrations, more so in patients with mild hyposalivation (607.57 ± 377.7 pg/ml = 66% decline) than in those with severe hyposalivation (1, 205 .35 ± 1,017.8 pg/ml = 62% decline; p = 0.398).
When comparing patients with and without erosive esophagitis no statistically significant difference could be found in salivary EGF concentrations (p = 0.562 for unstimulated saliva and p = 0.885 for stimulated saliva).
Discussion
Patients with Sjögren syndrome have been reported to have a greater likelihood of GERD and LPR. 7, 8, 23, 31 However, no study to date has been designed spe-cifically to establish the causes of this association. Salivary EGF deficiencies have been associated with the presence of both forms of reflux disease, so one would hypothesize that patients with acinar compromise, such as in Sjögren syndrome, would be a good clinical model to study the correlation between total salivary volume decreases and specific protein deficiencies in the genesis of GERD and LPR. We originally intended to compare the saliva of 2 distinct study groups of patients with Sjögren syndrome, one group with and another group without LPR. To our surprise, however, all 21 patients with Sjögren syndrome consecutively recruited for this study were found to have LPR, 13 of whom also had GERD (table 2) .
The diagnosis of LPR is controversial and relies largely on clinical symptoms and laryngopharyngeal signs of inflammation. [20] [21] [22] [24] [25] [26] These parameters are common to a number of other diseases that affect the laryngopharyngeal segment; thus, strict inclusion and exclusion criteria are required when attempting to study LPR. In the current study, only those patients who met the strict inclusion and exclusion criteria were enrolled. Considering that Sjögren syndrome is rare in the general population, 7, 9, 19 after applying the preestablished criteria, the studied population was reduced to a small number of patients in whom no other known cause of laryngopharyngeal or gastrointestinal aggression was identified.
Confirmation of the clinical diagnosis of LPR was based on the rationale that all other possible known causes of chronic laryngopharyngitis had been ruled out, and therefore any single test proving the presence of reflux disease would explain the laryngopharyngeal findings. 13, 14 Thus, patients with erosive esophagitis, which is recognized as a typical manifestation of GERD, did not undergo additional investigation. 26, 27 The remaining 13 patients underwent additional investigation with prolonged double-sensor esophageal pH monitoring. Interestingly, unlike most reports in the literature examining the sensitivity of esophageal pH monitoring in patients with suspected LPR, 20-22 the diagnostic sensitivity was 100% for the 13 patients with Sjögren syndrome who underwent this test.
Few studies have focused on the laryngeal manifestations of Sjögren syndrome. Belafsky and Postma in 2003 suggested that patients with Sjögren syndrome would be more susceptible to GERD and LPR due to esophageal dysmotility and loss of acid clearance capacity. 9 In the current series, only 4 of the 21 patients with Sjögren syndrome were found to have esophageal dysmotility, but all the patients presented with signs of chronic laryngitis. In accordance with the findings of the current study, Ogut and coworkers also reported significantly higher RSI and RFS scores in patients with Sjögren syndrome. 10 These studies point to the need for an enhanced understanding of the delicate mechanisms involved in the inflammatory signs found at the laryngopharyngeal segment of patients with Sjögren syndrome.
Salivary and gastric juice EGF concentrations have been reported to be decreased in patients with GERD, peptic ulcers, and erosive esophagitis. 11, 12 In the current series, however, patients with Sjögren syndrome and erosive esophagitis were not found to have significant salivary EGF deficiencies compared with those without erosive esophagitis. Likewise, the severity of hyposalivation, which should correspond to the breakdown of acinar function, could not account for differences in salivary EGF concentrations.
Interestingly, patients with severe hyposalivation were found to have significantly smaller declines in salivary EGF concentration after mechanical stimulation, most likely due to the severe glandular breakdown and to dilutional inability. Most of these patients were also found to have esophagitis, and 4 presented with esophageal dysmotility, again pointing to the quintessential role of saliva (fluid volume and chemical constituents) in maintaining homeostasis of the digestive tract. [2] [3] [4] [5] 8, [11] [12] [13] [14] 32 The current study failed to establish a qualitative difference in the saliva of patients with Sjögren syndrome that could help explain the above-mentioned abnormalities, as previously observed in nonxerostomic patients with LPR. 13, 14 Although no significant salivary EGF deficiencies were observed, our findings highlight the importance of further investigation into salivary characteristics of patients with Sjögren syndrome, and to the need for investigating and addressing LPR and GERD in these patients to minimize morbidity and improve quality of life.
Conclusion
Unlike previous studies that found significant EGF deficiencies in patients with reflux laryngitis and GERD, patients with Sjögren syndrome seem to have reflux caused by a decline in clearance capacity and not in specific salivary components, such as salivary EGF. * Mild hyposalivation was defined as a whole unstimulated salivary volume between 1 and 3 ml and/or whole stimulated salivary volume between 7 and 15 ml. Severe hyposalivation was defined as whole unstimulated salivary volume <1 ml and/or whole stimulated salivary volume <7 ml.
Key: EGF = epidermal growth factor.
